Loading...
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma
Malignant melanoma is the most deadly skin cancer, associated with rising incidence and mortality rates. Most of the patients with melanoma, treated with current targeted therapies, develop a drug resistance, causing tumor relapse. The attainment of a better understanding of novel cancer-promoting m...
Na minha lista:
| Udgivet i: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7327877/ https://ncbi.nlm.nih.gov/pubmed/32637583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.06.001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|